ICD-10: E24.2

Overview of Drug-Induced Cushing's Syndrome (ICD-10 Code E24.2)

Drug-induced Cushing's syndrome is a condition characterized by the excessive production of cortisol or cortisol-like substances due to the administration of certain medications. This syndrome is classified under the ICD-10 code E24.2, which specifically identifies cases where the condition arises as a direct result of pharmacological agents.

Clinical Description

Cushing's syndrome, in general, is a disorder that results from prolonged exposure to elevated levels of cortisol. When this condition is induced by drugs, it is often due to the use of corticosteroids, which are commonly prescribed for a variety of inflammatory and autoimmune conditions. The syndrome can manifest with a range of symptoms and clinical features, including:

• Weight Gain: Particularly in the trunk and face, leading to a characteristic "moon face."
• Skin Changes: Thinning of the skin, easy bruising, and the development of purple striae (stretch marks).
• Muscle Weakness: Especially in the proximal muscles, which can lead to difficulties in physical activities.
• Hypertension: Elevated blood pressure is common due to fluid retention and other metabolic changes.
• Hyperglycemia: Increased blood sugar levels, which can lead to steroid-induced diabetes.
• Psychological Effects: Mood swings, anxiety, and depression may occur due to hormonal imbalances.

Etiology

The primary cause of drug-induced Cushing's syndrome is the administration of exogenous corticosteroids, which can be given in various forms, including oral, intravenous, or topical. Other medications that may contribute to this condition include:

• Adrenocorticotropic Hormone (ACTH): Used in certain diagnostic tests or treatments.
• Certain Antineoplastic Agents: Some cancer treatments can mimic the effects of cortisol.
• Progestins: Hormonal therapies that may have glucocorticoid-like effects.

Diagnosis

Diagnosing drug-induced Cushing's syndrome involves a thorough clinical evaluation, including:

• Patient History: Detailed medication history to identify potential corticosteroid use or other relevant drugs.
• Physical Examination: Assessment of clinical signs and symptoms associated with Cushing's syndrome.
• Laboratory Tests: Measurement of cortisol levels in urine, saliva, or blood, along with suppression tests to evaluate adrenal function.

Management

Management of drug-induced Cushing's syndrome primarily focuses on the following strategies:

• Medication Review: Identifying and, if possible, discontinuing or tapering the offending medication under medical supervision.
• Symptomatic Treatment: Addressing specific symptoms such as hypertension, hyperglycemia, and psychological effects.
• Monitoring: Regular follow-up to assess the resolution of symptoms and any potential long-term effects of corticosteroid use.

Conclusion

Drug-induced Cushing's syndrome (ICD-10 code E24.2) is a significant clinical condition that arises from the use of certain medications, particularly corticosteroids. Understanding its clinical features, etiology, and management strategies is crucial for healthcare providers to effectively diagnose and treat affected patients. Early recognition and appropriate intervention can help mitigate the adverse effects associated with this syndrome, improving patient outcomes and quality of life.

Drug-induced Cushing's syndrome, classified under ICD-10 code E24.2, is a condition that arises from the prolonged use of certain medications, particularly glucocorticoids. This syndrome mimics the features of Cushing's disease, which is caused by endogenous overproduction of cortisol. Understanding the clinical presentation, signs, symptoms, and patient characteristics associated with drug-induced Cushing's syndrome is crucial for timely diagnosis and management.

Clinical Presentation

Overview

Drug-induced Cushing's syndrome typically occurs in patients who have been prescribed glucocorticoids for various medical conditions, such as autoimmune diseases, inflammatory disorders, or organ transplantations. The clinical presentation can vary based on the duration and dosage of glucocorticoid therapy.

Signs and Symptoms

The signs and symptoms of drug-induced Cushing's syndrome are similar to those seen in endogenous Cushing's syndrome and may include:

• Weight Gain: Patients often experience significant weight gain, particularly in the trunk and face, leading to a characteristic "moon face" appearance[1].
• Skin Changes: Thinning of the skin, easy bruising, and the development of striae (purple stretch marks) are common[2].
• Muscle Weakness: Proximal muscle weakness may occur, affecting the shoulders and hips, making it difficult for patients to perform daily activities[3].
• Hypertension: Elevated blood pressure is frequently observed in affected individuals[4].
• Hyperglycemia: Increased blood sugar levels can lead to steroid-induced diabetes mellitus[5].
• Mood Changes: Patients may experience mood swings, anxiety, or depression due to hormonal changes[6].
• Menstrual Irregularities: Women may report changes in their menstrual cycle, including amenorrhea or irregular periods[7].

Patient Characteristics

Certain patient characteristics can influence the risk and severity of drug-induced Cushing's syndrome:

• Duration of Therapy: The risk increases with the length of glucocorticoid treatment; prolonged use (typically over three months) is a significant risk factor[8].
• Dosage: Higher doses of glucocorticoids are more likely to induce Cushing's syndrome[9].
• Age and Gender: Older adults and women may be more susceptible to developing symptoms due to hormonal differences and age-related changes in metabolism[10].
• Underlying Conditions: Patients with pre-existing conditions such as obesity, diabetes, or hypertension may experience exacerbated symptoms when treated with glucocorticoids[11].

Diagnosis and Management

Diagnosis of drug-induced Cushing's syndrome involves a thorough clinical evaluation, including a detailed medication history to identify glucocorticoid use. Laboratory tests may include measuring serum cortisol levels, 24-hour urinary free cortisol, and suppression tests to confirm hypercortisolism[12].

Management typically involves tapering or discontinuing the offending glucocorticoid, if possible, and addressing the symptoms through supportive care and treatment of any complications, such as hypertension or diabetes[13].

Conclusion

Drug-induced Cushing's syndrome is a significant clinical concern for patients receiving glucocorticoid therapy. Recognizing the signs and symptoms, understanding patient characteristics, and implementing appropriate diagnostic and management strategies are essential for improving patient outcomes. Awareness among healthcare providers about this condition can lead to better monitoring and timely interventions, ultimately reducing the risk of long-term complications associated with prolonged glucocorticoid use.

Drug-induced Cushing's syndrome, classified under ICD-10 code E24.2, is a condition that arises due to the administration of certain medications that lead to excess cortisol levels in the body. Understanding the alternative names and related terms for this diagnosis can enhance clarity in medical documentation and communication. Below are some of the key terms associated with E24.2.

Alternative Names for Drug-Induced Cushing's Syndrome

1. Iatrogenic Cushing's Syndrome: This term emphasizes that the condition is caused by medical treatment, particularly the use of corticosteroids or other drugs that affect cortisol levels.

2. Corticosteroid-Induced Cushing's Syndrome: This name specifically highlights corticosteroids as the primary drugs responsible for inducing the syndrome.

3. Medication-Induced Cushing's Syndrome: A broader term that encompasses any medication that may lead to the development of Cushing's syndrome, not limited to corticosteroids.

4. Cushing's Disease (Drug-Induced): While Cushing's disease typically refers to a pituitary adenoma causing excess cortisol, this term can sometimes be used to describe cases where drug use mimics the disease's symptoms.

Related Terms

1. Cushing's Syndrome: A general term for the condition characterized by excessive cortisol, which can be caused by various factors, including tumors and medications.

2. Hypercortisolism: This term refers to the state of having high cortisol levels, which is a hallmark of Cushing's syndrome, including drug-induced cases.

3. Adrenal Insufficiency: While not directly synonymous, this term is relevant as it describes a condition where the adrenal glands do not produce adequate amounts of steroid hormones, which can be a concern when tapering off corticosteroids.

4. Corticosteroid Therapy: This term refers to the treatment involving corticosteroids, which can lead to drug-induced Cushing's syndrome if used inappropriately or for extended periods.

5. Endogenous Cushing's Syndrome: This term contrasts with drug-induced cases, referring to Cushing's syndrome caused by internal factors, such as tumors or adrenal hyperplasia.

Conclusion

Understanding the alternative names and related terms for ICD-10 code E24.2 is crucial for healthcare professionals involved in diagnosis, treatment, and documentation. These terms not only facilitate clearer communication but also help in identifying the underlying causes and appropriate management strategies for patients experiencing drug-induced Cushing's syndrome.

The diagnosis of Drug-induced Cushing's syndrome, classified under ICD-10 code E24.2, involves a comprehensive evaluation of clinical symptoms, medical history, and laboratory tests. Here’s a detailed overview of the criteria used for diagnosis:

Clinical Symptoms

Patients with Drug-induced Cushing's syndrome typically present with a range of symptoms associated with excess cortisol levels. Common clinical features include:

• Weight Gain: Particularly in the trunk and face, often described as "moon facies."
• Skin Changes: Thinning of the skin, easy bruising, and striae (purple stretch marks).
• Muscle Weakness: Proximal muscle weakness is frequently reported.
• Hypertension: Elevated blood pressure is common in these patients.
• Hyperglycemia: Increased blood sugar levels may be observed, leading to glucose intolerance or diabetes.
• Psychological Changes: Mood swings, depression, or anxiety can occur due to hormonal imbalances.

Medical History

A thorough medical history is crucial in diagnosing Drug-induced Cushing's syndrome. Key aspects include:

• Medication Review: Identification of corticosteroid use, either systemic or topical, is essential. This includes prescription medications, over-the-counter drugs, and any herbal supplements that may contain corticosteroids.
• Duration and Dosage: The length of time the patient has been on corticosteroids and the dosage used are critical factors in establishing a causal relationship with the symptoms.

Laboratory Tests

To confirm the diagnosis, several laboratory tests may be conducted:

• 24-Hour Urinary Free Cortisol Test: This test measures cortisol levels in urine collected over 24 hours. Elevated levels suggest hypercortisolism.
• Late-Night Salivary Cortisol Test: Salivary cortisol levels are typically low at night; elevated levels can indicate Cushing's syndrome.
• Dexamethasone Suppression Test: This test assesses the feedback mechanism of cortisol regulation. In normal individuals, dexamethasone suppresses cortisol production; in Cushing's syndrome, this suppression is impaired.

Differential Diagnosis

It is also important to differentiate Drug-induced Cushing's syndrome from other forms of Cushing's syndrome, such as:

• Cushing's Disease: Caused by a pituitary adenoma producing excess ACTH.
• Ectopic ACTH Syndrome: Due to non-pituitary tumors secreting ACTH.
• Adrenal Tumors: Primary adrenal tumors that produce cortisol independently.

Conclusion

The diagnosis of Drug-induced Cushing's syndrome (ICD-10 code E24.2) requires a multifaceted approach, including a detailed clinical assessment, thorough medication history, and specific laboratory tests to confirm elevated cortisol levels. Proper identification of the condition is essential for effective management and treatment, particularly in adjusting or discontinuing the offending medication. If you suspect Drug-induced Cushing's syndrome, consulting with an endocrinologist for further evaluation and management is advisable.

Drug-induced Cushing's syndrome, classified under ICD-10 code E24.2, is a condition resulting from the prolonged use of corticosteroids or other medications that can mimic the effects of cortisol in the body. Understanding the standard treatment approaches for this condition is crucial for effective management and patient care.

Understanding Drug-Induced Cushing's Syndrome

Cushing's syndrome occurs when there is an excess of cortisol in the body, which can lead to various symptoms such as weight gain, hypertension, diabetes, and skin changes. Drug-induced Cushing's syndrome specifically refers to cases where these symptoms arise due to pharmacological agents, particularly glucocorticoids used for conditions like asthma, rheumatoid arthritis, and autoimmune diseases[1][2].

Standard Treatment Approaches

1. Discontinuation or Adjustment of Medications

The first step in managing drug-induced Cushing's syndrome is often the discontinuation or adjustment of the offending medication. If the condition is identified early and the corticosteroid use is limited, symptoms may resolve after stopping the drug. However, it is essential to taper off corticosteroids gradually rather than stopping abruptly to avoid withdrawal symptoms and adrenal insufficiency[3][4].

2. Symptomatic Management

While the underlying cause is being addressed, symptomatic management may be necessary. This can include:

• Weight Management: Implementing dietary changes and exercise programs to help manage weight gain associated with Cushing's syndrome.
• Blood Pressure Control: Monitoring and managing hypertension through lifestyle changes and antihypertensive medications if necessary.
• Diabetes Management: Adjusting diabetes medications or insulin therapy to control blood sugar levels, as Cushing's syndrome can lead to insulin resistance[5].

3. Hormonal Replacement Therapy

In cases where the adrenal glands have been suppressed due to long-term corticosteroid use, patients may require hormonal replacement therapy. This is particularly important if the patient experiences adrenal insufficiency after stopping corticosteroids. Monitoring adrenal function through tests such as the ACTH stimulation test can guide the need for replacement therapy[6].

4. Psychological Support

Patients with Cushing's syndrome may experience psychological effects, including depression and anxiety. Providing psychological support, counseling, or referral to a mental health professional can be beneficial in managing these aspects of the condition[7].

5. Regular Monitoring and Follow-Up

Ongoing monitoring of the patient's symptoms and overall health is crucial. Regular follow-up appointments can help assess the resolution of symptoms and the need for any further interventions. This may include laboratory tests to monitor cortisol levels and other related parameters[8].

Conclusion

The management of drug-induced Cushing's syndrome primarily revolves around the identification and modification of the causative medication, alongside supportive care to address symptoms and complications. A multidisciplinary approach involving endocrinologists, primary care physicians, and mental health professionals can enhance patient outcomes. Regular monitoring and patient education about the condition are also vital for effective management and recovery. If you suspect drug-induced Cushing's syndrome, consult a healthcare provider for a tailored treatment plan.

References

1. A 15-Year Experience from Thailand - PMC - PubMed Central.
2. Clinical Characteristics and Treatment Outcomes in ...
3. Tips for Endocrinologists to Ensure Proper ICD-10 Coding.
4. Billing and Coding: Percutaneous Vertebral Augmentation.
5. Evaluation of preventable adverse drug reactions by ...
6. South African ICD-10 Technical User Guide.
7. ICD-10 International Statistical Classification of Diseases ...
8. ICD-10, International Statistical Classification of Diseases ...